+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nootropics Market Size, Share & Trends Analysis Report by Form (Capsules/ Tablets, Powder, Drinks), Distribution Channel (Online, Offline), Region, and Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 90 Pages
  • December 2023
  • Region: Global
  • Grand View Research
  • ID: 5516235
The global nootropics market size was estimated to reach USD 11.17 billion in 2030 and is expected to grow at a CAGR of 14.6% from 2023 to 2030. The global market has witnessed increased growth in the last few years, which is expected to continue over the forecast period. This growth is driven by the increasing awareness among consumers regarding the cognitive health benefits of nootropics and their desire to improve mental performance. As the global population ages, there is a growing interest in products that support brain health, and nootropics are seen as a viable option. In addition, the prevalence of stress and mental health concerns is propelling individuals to explore cognitive enhancers.

Nootropic capsules have higher penetration as they are easy to take and do not require any preparation or mixing. Consumers can simply swallow a capsule with water, making it a convenient option for those with busy lifestyles. Capsules provide precise and consistent dosages of nootropic ingredients. This is particularly important when it comes to cognitive enhancers, as accurate dosing is crucial for achieving the desired effects. Capsules are a common form of pharmaceuticals and dietary supplements, which can enhance the perceived credibility of nootropic products.

Nootropics manufacturers are increasingly prioritizing natural ingredients in response to the growing consumer demand for such products. For instance, in October 2021, XITE, a nootropic energy drinks brand, launched a nootropic vegan protein bar to appeal to the growing consumer base of mind health-conscious consumers. The bars are packed with nootropics, such as caffeine, L-theanine, and ashwagandha, which are claimed to improve cognitive function, focus, and energy level. Similarly, in April 2019, Gaia Herbs launched new vegan supplements called Bacopa made using Bacopa; Nootropic Focus made with saffron, lemon balm, and spearmint; and Agile Mind made with Bacopa, gingko, and turmeric.

Nootropics Market Report Highlights

  • Based on form, the capsule/ tablets nootropics segment held the largest share of 49.2% in 2022. Capsules and tablets effectively mask the unpleasant taste of many nootropics, making them easier to swallow compared to powdered supplements. In addition, the encapsulation or tableting process prolongs ingredients’ shelf life by shielding them from exposure to air and moisture, reducing the risk of contamination
  • In terms of distribution channel, the online segment is anticipated to grow at a CAGR of 16.2% from 2023 to 2030. The convenience and popularity of online shopping and the availability of a wide variety of nootropics through this channel are key factors driving the distribution segment
  • North America held a major share of over 41.2% of the global market in 2022. This can be attributed to the rising trend of health consciousness among North Americans, leading to a heightened interest in maintaining a healthy diet and lifestyle. The region's focus on wellness and preventive healthcare drives the demand for nootropics

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal database
1.3.3. Secondary Products & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Product Outlook
2.3. Distribution Channel Outlook
2.4. Regional Outlook
Chapter 3. Nootropics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Industry Value Chain Analysis
3.2.1. Sales/Retail Channel Analysis
3.2.2. Profit Margin Analysis
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Market Opportunities
3.3.4. Market Challenges
3.4. Industry Analysis - Porter’s Five Forces Analysis
3.5. Market Entry Strategies
Chapter 4. Consumer Behavior Analysis
4.1. Demographics Analysis
4.2. Consumer Trends and Preferences
4.3. Factors Affecting Buying Decision
4.4. Consumer Product Adoption
4.5. Key Observations & Findings
Chapter 5. Nootropics Market: Form Estimates & Trend Analysis
5.1. Form Movement Analysis & Market Share, 2022 & 2030
5.2. Capsules/Tablets
5.2.1. Market estimates and forecast, 2017-2030 (USD Million)
5.3. Powder
5.3.1. Market estimates and forecast, 2017-2030 (USD Million)
5.4. Drinks
5.4.1. Market estimates and forecast, 2017-2030 (USD Million)
5.5. Others
5.5.1. Market estimates and forecast, 2017-2030 (USD Million)
Chapter 6. Nootropics Market: Distribution Channel Range Estimates & Trend Analysis
6.1. Distribution Channel Movement Analysis & Market Share, 2022 & 2030
6.2. Offline
6.2.1. Market estimates and forecast, 2017-2030 (USD Million)
6.3. Online
6.3.1. Market estimates and forecast, 2017-2030 (USD Million)
Chapter 7. Nootropics Market: Regional Estimates & Trend Analysis
7.1. Regional Movement Analysis & Market Share, 2022 & 2030
7.2. North America
7.2.1. Market estimates and forecast, 2017-2030 (USD Million)
7.2.2. Market estimates and forecast, by form, 2017-2030 (USD Million)
7.2.3. Market estimates and forecast, by distribution channel, 2017-2030 (USD Million)
7.2.4. U.S.
7.2.4.1. Market estimates and forecast, 2017-2030 (USD Million)
7.2.4.2. Market estimates and forecast, by form, 2017-2030 (USD Million)
7.2.4.3. Market estimates and forecast, by distribution channel, 2017-2030 (USD Million)
7.2.5. Canada
7.2.5.1. Market estimates and forecast, 2017-2030 (USD Million)
7.2.5.2. Market estimates and forecast, by form, 2017-2030 (USD Million)
7.2.5.3. Market estimates and forecast, by distribution channel, 2017-2030 (USD Million)
7.2.6. Mexico
7.2.6.1. Market estimates and forecast, 2017-2030 (USD Million)
7.2.6.2. Market estimates and forecast, by form, 2017-2030 (USD Million)
7.2.6.3. Market estimates and forecast, by distribution channel, 2017-2030 (USD Million)
7.3. Europe
7.3.1. Market estimates and forecast, 2017-2030 (USD Million)
7.3.2. Market estimates and forecast, by form, 2017-2030 (USD Million)
7.3.3. Market estimates and forecast, by distribution channel, 2017-2030 (USD Million)
7.3.4. Germany
7.3.4.1. Market estimates and forecast, 2017-2030 (USD Million)
7.3.4.2. Market estimates and forecast, by form, 2017-2030 (USD Million)
7.3.4.3. Market estimates and forecast, by distribution channel, 2017-2030 (USD Million)
7.3.5. Italy
7.3.5.1. Market estimates and forecast, 2017-2030 (USD Million)
7.3.5.2. Market estimates and forecast, by form, 2017-2030 (USD Million)
7.3.5.3. Market estimates and forecast, by distribution channel, 2017-2030 (USD Million)
7.4. Asia-Pacific
7.4.1. Market estimates and forecast, 2017-2030 (USD Million)
7.4.2. Market estimates and forecast, by form, 2017-2030 (USD Million)
7.4.3. Market estimates and forecast, by distribution channel, 2017-2030 (USD Million)
7.4.4. China
7.4.4.1. Market estimates and forecast, 2017-2030 (USD Million)
7.4.4.2. Market estimates and forecast, by form, 2017-2030 (USD Million)
7.4.4.3. Market estimates and forecast, by distribution channel, 2017-2030 (USD Million)
7.4.5. India
7.4.5.1. Market estimates and forecast, 2017-2030 (USD Million)
7.4.5.2. Market estimates and forecast, by form, 2017-2030 (USD Million)
7.4.5.3. Market estimates and forecast, by distribution channel, 2017-2030 (USD Million)
7.5. Central & South America
7.5.1. Market estimates and forecast, 2017-2030 (USD Million)
7.5.2. Market estimates and forecast, by form, 2017-2030 (USD Million)
7.5.3. Market estimates and forecast, by distribution channel, 2017-2030 (USD Million)
7.5.4. Brazil
7.5.4.1. Market estimates and forecast, 2017-2030 (USD Million)
7.5.4.2. Market estimates and forecast, by form, 2017-2030 (USD Million)
7.5.4.3. Market estimates and forecast, by distribution channel, 2017-2030 (USD Million)
7.6. Middle East & Africa
7.6.1. Market estimates and forecast, 2017-2030 (USD Million)
7.6.2. Market estimates and forecast, by form, 2017-2030 (USD Million)
7.6.3. Market estimates and forecast, by distribution channel, 2017-2030 (USD Million)
7.6.4. UAE
7.6.4.1. Market estimates and forecast, 2017-2030 (USD Million)
7.6.4.2. Market estimates and forecast, by form, 2017-2030 (USD Million)
7.6.4.3. Market estimates and forecast, by distribution channel, 2017-2030 (USD Million)
Chapter 8. Competitive Analysis
8.1. Recent developments & impact analysis, by key market participants
8.2. Company Categorization
8.3. Participant’s Overview
8.4. Financial Performance
8.5. Product Benchmarking
8.6. Company Market Share Analysis, 2022 (%)
8.7. Company Heat Map Analysis
8.8. Strategy Mapping
8.9. List of key companies analyzed in this section include:
8.9.1. Onnit Labs, Inc.
8.9.2. Reckitt Benckiser Group PLC
8.9.3. Mental Mojo, LLC
8.9.4. NooCube
8.9.5. Mind Lab Pro (Performance Lab Group Ltd)
8.9.6. TruBrain
8.9.7. Neu Mind, LLC
8.9.8. Nooflux LLC
8.9.9. Zhou Nutrition
8.9.10. Kimera Koffee
List of Tables
Table 1 Nootropics market - Driving factor market analysis
Table 2 List of 14 nootropics that help enhance brain activity as well as performance
Table 3 Nootropics market- Restraint factor market analysis
Table 4 Nootropics market estimates & forecast, by form (USD Million)
Table 5 Nootropics market estimates & forecast, by distribution channel (USD Million)
Table 6 U.S. macro-economic outlay
Table 7 Canada macro-economic outlay
Table 8 Germany macro-economic outlay
Table 9 Italy macro-economic outlay
Table 10 China macro-economic outlay
Table 11 India macro-economic outlay
Table 12 Brazil macro-economic outlay
Table 13 South Africa macro-economic outlay
Table 14 Recent developments & impact analysis, by key market participants
Table 15 Company market share, 2022
Table 16 Company heat map analysis
Table 17 Key Companies launching new products
Table 18 Companies undergoing acquisitions
Table 19 Key Companies involved mergers and acquisitions
List of Figures
Figure 1 Nootropics market segmentation
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Primary research approaches
Figure 5 Primary research process
Figure 6 Market snapshot
Figure 7 Form segment snapshot
Figure 8 Distribution channel segment snapshot
Figure 9 Competitive landscape Snapshot
Figure 10 Global nootropics market size, 2017 to 2030 (USD Million)
Figure 11 Global nootropics market - penetration & growth prospect mapping
Figure 12 Nootropics market: Value chain analysis
Figure 13 Nootropics market: Sales channel
Figure 14 Nootropics market: Profit-margin analysis
Figure 15 Nootropics market: Dynamics
Figure 16 Global Nootropics Market Value; 2012, 2017 & 2022 (USD Million)
Figure 17 Nootropics market: Porter's Five Forces analysis
Figure 18 Roadmap of Nootropics Market
Figure 19 Consumption nootropics. by age, 2022
Figure 20 Consumption of supplements, by gender, 2022
Figure 21 Spending on supplements, by income group, 2022
Figure 22 Factors affecting buying decisions for nootropics
Figure 23 Nootropics market, by form: Key takeaways
Figure 24 Nootropics market, by form: Market share, 2022 & 2030
Figure 25 Nootropics market estimates & forecasts, by capsules/ tablets, 2017-2030 (USD Million)
Figure 26 Nootropics market estimates & forecasts, by powder, 2017-2030 (USD Million)
Figure 27 Nootropics market estimates & forecasts, by drinks, 2017-2030 (USD Million)
Figure 28 Nootropics market estimates & forecasts, by others, 2017-2030 (USD Million)
Figure 29 Nootropics market, by distribution channel: Key takeaways
Figure 30 Nootropics market, by distribution channel: Market share, 2022 & 2030
Figure 31 Nootropics market estimates & forecasts through online channel, 2017-2030 (USD Million)
Figure 32 Nootropics market estimates & forecasts through offline channel, 2017-2030 (USD Million)
Figure 33 Nootropics market revenue, by region, 2022 & 2030, (USD Million)
Figure 34 Regional marketplace: Key takeaways
Figure 35 North America nootropics market estimates & forecast, 2017-2030 (USD Million)
Figure 36 U.S. nootropics market estimates & forecast, 2017-2030 (USD Million)
Figure 37 U.S. ADHD Insights, 2021
Figure 38 Canada nootropics market estimates & forecast, 2017-2030 (USD Million)
Figure 39 Europe nootropics market estimates & forecast, 2017-2030 (USD Million)
Figure 40 Germany nootropics market estimates & forecast, 2017-2030 (USD Million)
Figure 41 Italy nootropics market estimates & forecast, 2017-2030 (USD Million)
Figure 42 Asia-Pacific nootropics market estimates & forecast, 2017-2030 (USD Million)
Figure 43 China nootropics market estimates & forecast, 2017-2030 (USD Million)
Figure 44 India nootropics market estimates & forecast, 2017-2030 (USD Million)
Figure 45 Central and South America nootropics market estimates & forecast, 2017-2030 (USD Million)
Figure 46 Brazil nootropics market estimates & forecast, 2017-2030 (USD Million)
Figure 47 Middle East & Africa nootropics market estimates & forecast, 2017-2030 (USD Million)
Figure 48 UAE nootropics market estimates & forecast, 2017-2030 (USD Million)
Figure 49 Company market share analysis, 2022
Figure 50 Strategic framework of nootropics market

Companies Mentioned

  • Onnit Labs, Inc. 
  • Reckitt Benckiser Group PLC
  • Mental Mojo, LLC
  • NooCube
  • Mind Lab Pro (Performance Lab Group Ltd)
  • TruBrain
  • Neu Mind, LLC
  • Nooflux LLC
  • Zhou Nutrition
  • Kimera Koffee

Methodology

Loading
LOADING...

Table Information